Chewy Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Chewy is expected to report fiscal Q2 EPS of $0.36, up from $0.33 a year earlier, on consensus revenue of $3.32 billion versus $3.10 billion last year. While the company beat first-quarter expectations in June, it lowered fiscal 2026 sales guidance, prompting several analysts to reduce price targets. Recent views remain divided, ranging from RBC's $34 Outperform target to Rosenblatt's $25 Neutral target; shares closed at $23.66, down 1.3% Friday.

Analysis

CHWY’s valuation setup is likely governed less by the modest EPS comparison and more by whether recurring Autoship revenue can reaccelerate without renewed fulfillment and marketing investment. The key earnings variables are active-customer growth, net adds, Autoship mix, gross-margin durability, and management’s full-year revenue framework; a beat driven only by cost control would be lower quality and unlikely to sustain multiple expansion. Conversely, evidence that customer acquisition costs are rising would reinforce the bear case that Amazon (AMZN), Walmart (WMT), and pet-specialty chains are converting pet-food convenience into a structurally lower-margin category.

The immediate reaction could be asymmetric because prior guidance resets leave the stock vulnerable to another outlook reduction, while a clean reiteration with improving customer metrics would force short-covering. Over the next 1-3 months, the catalyst path is proof that discretionary categories—pharmacy, private label, and higher-margin hardgoods—can offset slower consumables growth; this would matter more to EBIT than headline revenue. Over 6-18 months, the central issue is whether CHWY can monetize its customer base through healthcare and advertising rather than compete solely on delivery economics, where scale advantages favor AMZN and WMT.

Consensus may be overly focused on a binary earnings beat/miss. A flat-to-positive revenue outlook coupled with sequential active-customer stabilization could be enough for upside even if revenue remains subdued, since expectations appear anchored to continued estimate cuts. The falsifier for a constructive post-print view is a second consecutive guidance reduction, declining Autoship penetration, or gross-margin pressure that cannot be attributed to temporary freight or mix effects.

Key Decisions for Investors

• Do not establish a directional pre-earnings CHWY position without implied-volatility and short-interest data; the article provides insufficient evidence of an informational edge relative to event risk.
• Conditional long CHWY only after results if management reiterates or raises the revenue outlook and reports sequential improvement in active customers or Autoship penetration. Target a 10-15% tactical move over 1-3 months; exit on a close below the post-earnings low or any subsequent guidance cut.
• If revenue guidance is reduced again while gross margin is maintained primarily through expense restraint, consider a 1-3 month pair trade: short CHWY / long WMT. The thesis is that competitive convenience and fulfillment scale shift pet-category economics toward WMT; cover if CHWY demonstrates accelerating customer growth and stable marketing efficiency.
• Monitor AMZN and WMT pet-category commentary, CHWY customer-acquisition spend, and pharmacy/advertising contribution at the next reporting cycle. A measurable improvement in these non-consumables profit pools would invalidate the pure commodity-retail short thesis.